| General Information of This Metabolic Reaction (MR) (ID:
MR010851) |
| Formula |
|
| Reactant |
Ala-TFV |
Product |
Tenofovir(TFV) |
|
Reactant Info
|
Product Info
|
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
|
Metabolic Type
|
Unclear
-
Unclear
|
|
|
|
|
|
|
|
| Other MR(s) Related to The Reactant of This MR |
|
Other MR(s) That Produce The Reactant of This MR
|
|
|
| Other MR(s) Related to The Product of This MR |
|
Other MR(s) That Produce The Product of This MR
|
|
|
|
Other MR(s) That Metabolize The Produtc of This MR
|
|
|
| References |
| 1 |
Implications of efficient hepatic delivery by tenofovir alafenamide (GS-7340) for hepatitis B virus therapy
|
| 2 |
Bictegravir/Emtricitabine/Tenofovir Alafenamide: a review in HIV-1 infection. Drugs. 2018 Nov;78(17):1817-1828.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.